[Experimental therapy of colibacillary pyelonephritis in rats].
D000085:Acetates / Q000627:therapeutic use; D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D003497:Cyclic N-Oxides / Q000627:therapeutic use*; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D000432:Methanol / Q000627:therapeutic use; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D051381:Rats; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000085:Acetates; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D003497:Cyclic N-Oxides; D011743:Pyrimidines; D011799:Quinazolines; D013449:Sulfonamides; D009268:Nalidixic Acid; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D013752:Tetracycline; D010400:Penicillin G; D000432:Methanol
Eksperimental'naia terpaiia kolibatsilliarnogo pielonefrita u krys.